Skip to content

Nuvation Bio NUVB Short- term Investments

Short- term Investments at other companies

Nuvalent, Inc. logo
Nuvalent, Inc.NUVL
IDEAYA Biosciences, Inc. logo
IDEAYA Biosciences, Inc.IDYA
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
Tango Therapeutics logo
Tango TherapeuticsTNGX
Roivant Sciences logo
Roivant SciencesROIV
Gilead Sciences logo
Gilead SciencesGILD

Other financials

Income statement

See full
Revenue$83.2M+2,599%
Gross profit$9.8M+1,340%
Operating income$3.9M+107%
Net income$5.4M+110%
EPS (diluted)$0.01+106%

Balance sheet

See full
Cash & equivalents$125.4M+161%
Total debt$57.2M+401%
Total equity$319.6M-23.8%
Total assets$610.2M+23.9%

Cash flow

See full
Operating cash flow$5.1M+112%
CapEx$48.0K-33.3%
Free cash flow$5.0M+112%

Valuation

See full
Market cap$2.1B+150%
Enterprise value$2.03B+154%
P/S14.7×-62.0×

Profitability

See full
Gross margin54.3%+39.5pp
Operating margin-105%-52.0pp
Net margin-102.1%-50.6pp
FCF margin-93.5%-45.2pp

Returns & leverage

See full
Return on equity-39.5%-15.8pp
Debt / equity0.2×+0.2×
Current ratio7.4×-1.6×

Where this comes from

Reported directly by Nuvation Bio in its filing.

Tagged under the XBRL concept us-gaap:MarketableSecuritiesCurrent.

The official record: Nuvation Bio’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Nuvation Bio's short- term investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Nuvation Bio's short- term investments?
Nuvation Bio (NUVB) reported short- term investments of $408.34M in Q1 2026.
How has Nuvation Bio's short- term investments changed year-over-year?
Nuvation Bio's short- term investments decreased by 1.3% year-over-year, from $413.7M to $408.34M.
What is the long-term trend for Nuvation Bio's short- term investments?
Over 5 years (2020 to 2025), Nuvation Bio's short- term investments has grown at a 14.4% compound annual growth rate (CAGR), from $186M to $365.13M.